UBS Group AG - NABRIVA THERAPEUTICS AG ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 24 filers reported holding NABRIVA THERAPEUTICS AG in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of NABRIVA THERAPEUTICS AG
ValueSharesWeighting
Q4 2016$7,000
-41.7%
1,134
-16.9%
0.00%–
Q1 2016$12,000
-7.7%
1,365
+4.7%
0.00%–
Q4 2015$13,000–1,304–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS AG in Q4 2016.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS AG shareholders